Known targets — ChEMBL curated mechanism
CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.50 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.49 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.48 |
| ▸ | APAF1 | O14727 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2181552 | 1.00 | LMNA (0.59) | LMNACYP2C9KCNH2CYP2D6CYP2C19 | |
| SCHEMBL2181688 | 1.00 | LMNA (0.59) | LMNACYP2C9KCNH2CYP2D6CYP2C19 | |
| SCHEMBL31327346 | 1.00 | LMNA (0.59) | LMNACYP2C9KCNH2CYP2D6CYP2C19 | |
| SCHEMBL699895 | 1.00 | LMNA (0.59) | LMNACYP2C9KCNH2CYP2D6CYP2C19 | |
| SCHEMBL8723514 | 1.00 | LMNA (0.59) | LMNACYP2C9KCNH2CYP2D6CYP2C19 | |
| SCHEMBL31327347 | 1.00 | LMNA (0.59) | LMNACYP2C9KCNH2CYP2D6CYP2C19 | |
| SCHEMBL331065 | 1.00 | LMNA (0.59) | LMNACYP2C9KCNH2CYP2D6CYP2C19 | |
| Cetrimonium SCHEMBL121980 | 1.00 | LMNA (0.59) | LMNACYP2C9KCNH2CYP2D6CYP2C19 | |
| Cetrimonium SCHEMBL5678134 | 0.98 | KCNH2 (0.57) | LMNACYP2C9KCNH2CYP2D6CYP2C19 | |
| Cetrimonium SCHEMBL28609304 | 0.98 | KCNH2 (0.57) | LMNACYP2C9KCNH2CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119240719-A | Hollow silicon dioxide microsphere with double-layer shell structure and preparation method thereof | 长兴特殊材料（珠海）有限公司 | 2025-01-03 | — | — | CN | disclosed |
| EP-2589701-B1 | METHOD FOR PRODUCING SIZING AGENT-COATED CARBON FIBERS, AND SIZING AGENT-COATED CARBON FIBERS | TORAY INDUSTRIES (JP) | 2019-08-21 | — | — | EP | disclosed |
| US-10184034-B2 | Carbon fiber forming raw material, formed material, and carbon fiber-reinforced composite material | TORAY INDUSTRIES, INC. (JP) | 2019-01-22 | — | — | US | disclosed |
| US-9932300-B2 | N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2018-04-03 | — | — | US | disclosed |
| EP-2765155-B1 | CARBON FIBER-REINFORCED THERMOPLASTIC RESIN MOLDING MATERIAL AND METHODS FOR PRODUCING SAME | TORAY INDUSTRIES (JP) | 2018-03-14 | — | — | EP | disclosed |
| EP-2295484-B1 | POLYMERIZABLE COMPOSITION FOR POLYTHIOURETHANE OPTICAL MATERIAL, POLYTHIOURETHANE OPTICAL MATERIAL OBTAINED FROM SAME POLYMERIZABLE COMPOSITION, AND POLYMERIZATION CATALYST FOR POLYTHIOURETHANE OPTICAL MATERIAL | MITSUI CHEMICALS INC (JP) | 2018-01-17 | — | — | EP | disclosed |
| EP-2407498-B1 | Polymerizable composition for polythiourethane optical material, polythiourethane optical material obtained from the polymerizable composition, and polymerization catalyst for polythiourethane optical material | MITSUI CHEMICALS INC (JP) | 2017-11-15 | — | — | EP | disclosed |
| US-9771681-B2 | Method for producing sizing agent-coated carbon fibers, and sizing agent-coated carbon fibers | TORAY INDUSTRIES, INC. (JP) | 2017-09-26 | — | — | US | disclosed |
| US-9593444-B2 | Method for producing sizing agent-coated carbon fibers, and sizing agent-coated carbon fibers | TORAY INDUSTRIES, INC. (JP) | 2017-03-14 | — | — | US | disclosed |
| US-20160318857-A1 | N,N'-Diarylurea Compounds and N,N'-Diarylthiourea Compounds as Inhibitors of Translation Initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2016-11-03 | — | — | US | disclosed |
| EP-2789648-A1 | CARBON FIBER MOLDING MATERIAL, MOLDING MATERIAL, AND CARBON FIBER-STRENGTHENING COMPOSITE MATERIAL | Toray Industries, Inc. (JP) | 2014-10-15 | — | — | EP | disclosed |
| US-20140228519-A1 | CARBON FIBER-REINFORCED THERMOPLASTIC RESIN COMPOSITION, MOLDING MATERIAL, PREPREG, AND METHODS FOR PRODUCING SAME | TORAY INDUSTRIES, INC. (JP) | 2014-08-14 | — | — | US | disclosed |
| EP-2765155-A1 | CARBON FIBER-REINFORCED THERMOPLASTIC RESIN COMPOSITION, MOLDING MATERIAL, PREPREG, AND METHODS FOR PRODUCING SAME | Toray Industries, Inc. (JP) | 2014-08-13 | — | — | EP | disclosed |
| EP-2589701-A1 | METHOD FOR PRODUCING SIZING AGENT-COATED CARBON FIBERS, AND SIZING AGENT-COATED CARBON FIBERS | Toray Industries, Inc. (JP) | 2013-05-08 | — | — | EP | disclosed |
| US-20130089736-A1 | METHOD FOR PRODUCING SIZING AGENT-COATED CARBON FIBERS, AND SIZING AGENT-COATED CARBON FIBERS | TORAY INDUSTRIES, INC. (JP) | 2013-04-11 | — | — | US | disclosed |
| US-8304507-B2 | Polymerizable composition for polythiourethane optical material, polythiourethane optical material obtained from the polymerizable composition, and polymerization catalyst for polythiourethane optical material | MITSUI CHEMICALS, INC. (JP) | 2012-11-06 | — | — | US | disclosed |
| US-20120115915-A1 | N,N'-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-05-10 | — | — | US | disclosed |
| EP-2407498-A2 | Polymerizable composition for polythiourethane optical material, polythiourethane optical material obtained from the polymerizable composition, and polymerization catalyst for polythiourethane optical material | Mitsui Chemicals, Inc. (JP) | 2012-01-18 | — | — | EP | disclosed |
| US-20110112269-A1 | POLYMERIZABLE COMPOSITION FOR POLYTHIOURETHANE OPTICAL MATERIAL, POLYTHIOURETHANE OPTICAL MATERIAL OBTAINED FROM THE POLYMERIZABLE COMPOSITION, AND POLYMERIZATION CATALYST FOR POLYTHIOURETHANE OPTICAL MATERIAL | MITSUI CHEMICALS, INC. (JP) | 2011-05-12 | — | — | US | disclosed |
| EP-2295484-A1 | POLYMERIZABLE COMPOSITION FOR POLYTHIOURETHANE OPTICAL MATERIAL, POLYTHIOURETHANE OPTICAL MATERIAL OBTAINED FROM SAME POLYMERIZABLE COMPOSITION, AND POLYMERIZATION CATALYST FOR POLYTHIOURETHANE OPTICAL MATERIAL | Mitsui Chemicals, Inc. (JP) | 2011-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160318857-A1 | N,N'-Diarylurea Compounds and N,N'-Diarylthiourea Compounds as Inhibitors of Translation Initiation | NSUN2, EIF2AK2, RNGTT | LMNA 448/4885CYP2C9 4884/4885KCNH2 4551/4885 |
| US-20120115915-A1 | N,N'-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION | NSUN2, EIF2AK2, RNGTT | LMNA 448/4885CYP2C9 4884/4885KCNH2 4551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.